Single Source · Yahoo Finance
This is one outlet's own report from Yahoo Finance — the article as it was filed. Other outlets are covering the same event; open the full story to compare every source side by side.
See the full story · 1 sourcesAIPROPX ReportYahoo Finance · 1h ago
This LSD-Based Drug Just Scored Again. Definium Stock Soars.
Definium Therapeutics (DFTX) unveiled the second positive Phase 3 study for its LSD-based drug on Thursday, and the biotech stock jumped. Patients with generalized anxiety disorder, or GAD, showed a 5.4-point improvement compared with a placebo on the 56-point Hamilton Anxiety Rating Scale. That beat the 4-point improvement investors had been hoping to see, RBC Capital Markets analyst Brian Abrahams…